Your browser doesn't support javascript.
loading
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug.
Brunetti, Jlenia; Pillozzi, Serena; Falciani, Chiara; Depau, Lorenzo; Tenori, Eleonora; Scali, Silvia; Lozzi, Luisa; Pini, Alessandro; Arcangeli, Annarosa; Menichetti, Stefano; Bracci, Luisa.
Afiliação
  • Brunetti J; University of Siena, Department of Medical Biotechnologies, Siena, 53100, Italy.
  • Pillozzi S; University of Florence, Department of Experimental and Clinical Medicine, Florence, 50139, Italy.
  • Falciani C; SetLance srl, Toscana Life Sciences, Siena, 53100, Italy.
  • Depau L; University of Siena, Department of Medical Biotechnologies, Siena, 53100, Italy.
  • Tenori E; University of Florence, Department of Chemistry, Florence, 50019, Italy.
  • Scali S; University of Siena, Department of Medical Biotechnologies, Siena, 53100, Italy.
  • Lozzi L; University of Siena, Department of Medical Biotechnologies, Siena, 53100, Italy.
  • Pini A; University of Siena, Department of Medical Biotechnologies, Siena, 53100, Italy.
  • Arcangeli A; University of Florence, Department of Experimental and Clinical Medicine, Florence, 50139, Italy.
  • Menichetti S; University of Florence, Department of Chemistry, Florence, 50019, Italy.
  • Bracci L; University of Siena, Department of Medical Biotechnologies, Siena, 53100, Italy.
Sci Rep ; 5: 17736, 2015 Dec 02.
Article em En | MEDLINE | ID: mdl-26626158

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Peptídeos / Neoplasias da Mama / Portadores de Fármacos / Paclitaxel / Neoplasias Mamárias Experimentais Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Peptídeos / Neoplasias da Mama / Portadores de Fármacos / Paclitaxel / Neoplasias Mamárias Experimentais Idioma: En Ano de publicação: 2015 Tipo de documento: Article